Repurposing Tecfidera for cancer
Authors:
Open Access
- 1 July 2016
- journal article
- Published by Impact Journals, LLC in Aging
- Vol. 8 (7) , 1289-1290
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Rationally Repurposing Ruxolitinib (Jakafi®) as a Solid Tumor TherapeuticFrontiers in Oncology, 2016
- Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cellsin vitroandin vivoOncotarget, 2016
- Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROSOncotarget, 2016
- Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistanceCancer Biology & Therapy, 2015
- Nexavar/Stivarga and Viagra Interact to Kill Tumor CellsJournal of Cellular Physiology, 2015
- Regulation of dimethyl-fumarate toxicity by proteasome inhibitorsCancer Biology & Therapy, 2014
- PDE5 Inhibitors Enhance Celecoxib Killing in Multiple Tumor TypesJournal of Cellular Physiology, 2014